Showing results (1-10 of 178) with videos related to

Sort By:
Pageof 18
Contributions to Nephrology|December 13, 2016
Klotho as a Therapeutic Target during the Development of Renal FibrosisShigehiro Doi, Takao Masaki
The Journal of Vascular Access|September 10, 2015
Vascular access intervention by a nephrologist in HiroshimaShigehiro Doi, Takao Masaki
Clinical and Experimental Nephrology|June 9, 2021
N-terminal pro brain natriuretic peptide predicts both all-cause and cardiovascular disease mortality in Japanese hemodialysis patientsAyaka Satoh, Shigehiro Doi, Takayuki Naito, et al.
The International Journal of Artificial Organs|March 17, 2018
N-terminal pro brain natriuretic peptide as a cardiac biomarker in Japanese hemodialysis patientsMinako Shimizu, Shigehiro Doi, Ayumu Nakashima, et al.
Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy|May 28, 2008
Calcium channel antagonists reduce restenosis after percutaneous transluminal angioplasty of an arteriovenous fistula in hemodialysis patientsShigehiro Doi, Takao Masaki, Kenichiro Shigemoto, et al.
Clinical and Experimental Nephrology|July 15, 2022
N-terminal pro-brain natriuretic peptide predicts hospitalization for ischemic stroke in Japanese hemodialysis patientsMai Yamaoka, Mahoko Yoshida, Ayumu Nakashima, et al.
Scientific Reports|September 21, 2018
TGF-β1 promotes expression of fibrosis-related genes through the induction of histone variant H3.3 and histone chaperone HIRAToshihiro Shindo, Shigehiro Doi, Ayumu Nakashima, et al.
Kidney International|October 2, 2019
Inhibition of the H3K4 methyltransferase MLL1/WDR5 complex attenuates renal senescence in ischemia reperfusion mice by reduction of p16INK4aHironori Shimoda, Shigehiro Doi, Ayumu Nakashima, et al.
Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy|July 28, 2004
Increased serum osteoprotegerin level in older and diabetic hemodialysis patientsShigehiro Doi, Noriaki Yorioka, Takao Masaki, et al.
Nephrology (Carlton, Vic.)|August 26, 2016
Oral iron supplementation with sodium ferrous citrate reduces the serum intact and c-terminal fibroblast growth factor 23 levels of maintenance haemodialysis patientsKazuomi Yamashita, Sonoo Mizuiri, Yoshiko Nishizawa, et al.
Pageof 18